(IN BRIEF) The University of Liverpool has partnered with Boston-based BPGbio, Inc. to use artificial intelligence to accelerate the discovery of new medicines through its Civic HealthTech Innovation Zone, analysing large-scale healthcare data to uncover causal links in disease and … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Financial, Healthcare, Industrial, Investment, Management, Pharma & Biotech, Science, Technology, United Kingdom
Tagged artificial intelligence, BPGbio Inc, causal inference, CHI-Zone, Civic HealthTech Innovation Zone, Claire Eyers, drug discovery, Iain Buchan, Investment Zone Programme, Life Sciences Innovation Zone, Liverpool City Region, Mayor Steve Rotheram, multi-omics, NAi Bayesian AI, Niven Narain, Peter Green, precision medicine, University of Liverpool, University of Liverpool and BPGbio Launch Data-Driven Collaboration to Transform Mechanism-Based Drug Discovery
(IN BRIEF) The Luxembourg Institute of Health (LIH) has announced five lecture series beginning this autumn and continuing through 2026, covering themes from microbiome research and causal inference to proteomics, cancer immunotherapy, and epidemiology. Led by LIH principal investigators and … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Luxembourg, Management, Marketing, News, Science, Technology
Tagged Allini Mafra Da Costa, Bassam Janji, biomedical lecture series, cancer research, causal inference, Claudine Backes, epidemiology, FNR, Gunnar Dittmar, Jason Settels, Johannes Meiser, LIH, LISER, LIST, Luxembourg Institute of Health, Mahesh Desai, MICRO-PATH DTU, microbiome, National Cancer Registry, proteomics, Sophie Pilleron, University of Luxembourg
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?